{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:59:04Z","timestamp":1770501544215,"version":"3.49.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ejca.2005.09.017","type":"journal-article","created":{"date-parts":[[2005,12,2]],"date-time":"2005-12-02T12:29:15Z","timestamp":1133526555000},"page":"295-309","source":"Crossref","is-referenced-by-count":61,"title":["Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"42","author":[{"given":"Katrien","family":"Swerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara De","family":"Moerloose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Dhooge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Laureys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Philipp\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2005.09.017_bib1","series-title":"Principles and Practice in Pediatric Oncology","first-page":"409","article-title":"Acute lymphoblastic leukemia","author":"Margolin","year":"1997"},{"key":"10.1016\/j.ejca.2005.09.017_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/02841869109091819","article-title":"Genetic mechanisms of drug resistance: a review","volume":"30","author":"Borst","year":"1991","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib3","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1038\/sj.onc.1206932","article-title":"Introduction to resistance to anticancer agents","volume":"22","author":"Kruh","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2005.09.017_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"Surface glycoprotein modulating drug permeability in chinese-hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejca.2005.09.017_bib5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejca.2005.09.017_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.leu.2401694","article-title":"Novel mechanisms of drug resistance in leukemia","volume":"14","author":"Ross","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1242\/jcs.113.11.2011","article-title":"The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)","volume":"113","author":"Litman","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ejca.2005.09.017_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ijc.10100","article-title":"Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization","volume":"97","author":"Kage","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm0695-578","article-title":"The drug resistance-related protein LRP is the human major vault protein","volume":"1","author":"Scheffer","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2005.09.017_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF01570737","article-title":"Localization of multidrug resistance-associated DNA sequences to human chromosome 7","volume":"12","author":"Fojo","year":"1986","journal-title":"Somat Cell Mol Genet"},{"key":"10.1016\/j.ejca.2005.09.017_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00272381","article-title":"Localization of the human multiple drug resistance gene, MDR1, to 7q21.1","volume":"77","author":"Callen","year":"1987","journal-title":"Hum Genet"},{"key":"10.1016\/j.ejca.2005.09.017_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/324485a0","article-title":"Homology between P-glycoprotein and a bacterial hemolysin transport protein suggests a model for multidrug resistance","volume":"324","author":"Gerlach","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2005.09.017_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0092-8674(86)90594-5","article-title":"Mammalian multidrug resistance gene \u2013 complete cDNA sequence indicates strong homology to bacterial transport proteins","volume":"47","author":"Gros","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2005.09.017_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0092-8674(86)90595-7","article-title":"Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells","volume":"47","author":"Chen","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2005.09.017_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/346362a0","article-title":"Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport","volume":"346","author":"Hyde","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2005.09.017_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","article-title":"The biochemistry of P-glycoprotein-mediated multidrug resistance","volume":"58","author":"Endicott","year":"1990","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ejca.2005.09.017_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","article-title":"ABC transporters: from microorganisms to man","volume":"8","author":"Higgins","year":"1992","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.ejca.2005.09.017_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","article-title":"Biochemistry of multidrug resistance mediated by the multidrug transporter","volume":"62","author":"Gottesman","year":"1993","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ejca.2005.09.017_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1574-6976.1997.tb00345.x","article-title":"Mechanisms of multidrug transporters","volume":"21","author":"Bolhuis","year":"1997","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ejca.2005.09.017_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0968-0004(92)90419-A","article-title":"Is the multidrug transporter a flippase","volume":"17","author":"Higgins","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ejca.2005.09.017_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0092-8674(94)90248-8","article-title":"Flip-flop: the transmembrane translocation of lipids","volume":"79","author":"Higgins","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2005.09.017_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib23","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(91)90141-K","article-title":"Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells","volume":"66","author":"Chaudhary","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2005.09.017_bib26","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.V80.11.2735.bloodjournal80112735","article-title":"Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes","volume":"80","author":"Chaudhary","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib27","first-page":"1748","article-title":"Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines","volume":"50","author":"Ford","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib28","first-page":"155","article-title":"Pharmacology of drugs that alter multidrug resistance in cancer","volume":"42","author":"Ford","year":"1990","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ejca.2005.09.017_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/0929867023371175","article-title":"Inhibitors of multidrug resistance to antitumor agents (MDR)","volume":"9","author":"Avendano","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ejca.2005.09.017_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ijc.2910460429","article-title":"Modulation of multidrug resistance by verapamil or MDR1 antisense oligodeoxynucleotide does not change the high susceptibility to lymphokine activated killers in MDR-resistant human carcinoma (Lovo) line","volume":"46","author":"Rivoltini","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib31","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.1021\/bi00086a022","article-title":"Differential modulation of P-glycoprotein transport by protein kinase inhibition","volume":"32","author":"Bates","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejca.2005.09.017_bib32","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/sj.gt.3302269","article-title":"Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1","volume":"11","author":"Yague","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejca.2005.09.017_bib33","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1073\/pnas.89.13.5824","article-title":"Efficient inhibition of P-glycoprotein mediated multidrug resistance with a monoclonal antibody","volume":"89","author":"Mechetner","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib34","first-page":"4427","article-title":"Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug resistant transgenic mice","volume":"52","author":"Mickisch","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib35","first-page":"1810","article-title":"Reversal of vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft","volume":"52","author":"Rittmanngrauer","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-409X(02)00175-8","article-title":"Considerations in the design and development of transport inhibitors as adjuncts to drug therapy","volume":"55","author":"Dantzig","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejca.2005.09.017_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2005.09.017_bib38","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2003-07-2490","article-title":"Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies","volume":"104","author":"Mahadevan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib39","doi-asserted-by":"crossref","unstructured":"Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005 [Epub ahead of print].","DOI":"10.1038\/sj.leu.2403927"},{"key":"10.1016\/j.ejca.2005.09.017_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/beha.2000.0124","article-title":"Chemotherapy resistance in acute myeloid leukaemia","volume":"14","author":"Sonneveld","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ejca.2005.09.017_bib41","first-page":"821","article-title":"Cyclosporine A as a modifier agent in the salvage treatment of acute leukemia (AL)","volume":"7","author":"Marie","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib42","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1200\/JCO.1992.10.11.1730","article-title":"Feasibility of using quinine, a potential multidrug resistance reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia","volume":"10","author":"Solary","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.ejca.2005.09.017_bib44","first-page":"327","article-title":"MDR1 gene expression in childhood acute lymphoblastic leukemias and lymphomas \u2013 a critical evaluation by 4 techniques","volume":"8","author":"Brophy","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib45","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1073\/pnas.83.20.7785","article-title":"Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies","volume":"83","author":"Hamada","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib46","first-page":"815","article-title":"Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies","volume":"63","author":"Grogan","year":"1990","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2005.09.017_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cyto.990200306","article-title":"Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein","volume":"20","author":"Lehne","year":"1995","journal-title":"Cytometry"},{"key":"10.1016\/j.ejca.2005.09.017_bib48","first-page":"1633","article-title":"Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine123 in human tumors","volume":"9","author":"Efferth","year":"1989","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib49","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1021\/bi00011a044","article-title":"Kinetics of transport of dialkyloxacarbocyanines in multidrug-resistant cell lines overexpressing P-glycoprotein: interrelationship of dye alkyl chain length, cellular flux, and drug resistance","volume":"34","author":"Wadkins","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejca.2005.09.017_bib50","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood.V97.2.502","article-title":"JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia","volume":"97","author":"Legrand","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib51","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/0277-5379(89)90367-2","article-title":"Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphoblastic leukaemia","volume":"25","author":"Ubezio","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF02093722","article-title":"Detection of multidrug resistant protein, P-glycoprotein in childhood leukemia and lymphoma","volume":"150","author":"Mizuno","year":"1991","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejca.2005.09.017_bib53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/bjc.1992.304","article-title":"MDR1\/P-glycoprotein, topoisomerase, and glutathione-S-transferase-pi gene expression in primary and relapsed state adult and childhood leukemias","volume":"66","author":"Gekeler","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib54","first-page":"23","article-title":"Sequential analysis of P-glycoprotein expression in childhood acute lymphoblastic leukemia","volume":"34","author":"Kingreen","year":"1992","journal-title":"Hematol Blood Transfus"},{"key":"10.1016\/j.ejca.2005.09.017_bib55","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bjc.1992.146","article-title":"Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukemia","volume":"65","author":"Pieters","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib56","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V82.12.3787.bloodjournal82123787","article-title":"Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia","volume":"82","author":"Fenneteau","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib57","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1182\/blood.V81.9.2394.2394","article-title":"Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications","volume":"81","author":"Goasguen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib58","first-page":"311","article-title":"Expression of the multidrug transporter, P-glycoprotein, in childhood leukemia: a prospective clinical study","volume":"1","author":"Dhooge","year":"1994","journal-title":"Int J Pediat Hematol Onc"},{"key":"10.1016\/j.ejca.2005.09.017_bib59","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/bjc.1994.462","article-title":"P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukemia","volume":"70","author":"Sauerbrey","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib60","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.1995.tb03312.x","article-title":"Expression of mdr1, mrp, topoisomerase-II-alpha\/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukemias","volume":"89","author":"Beck","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.017_bib61","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0145-2126(95)00092-5","article-title":"Prognostic value of rhodamine-efflux and MDR-1\/P-170 expression in childhood acute leukemia","volume":"19","author":"Tafuri","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V88.1.309.309","article-title":"Correlation of P-glycoprotein expression and function in childhood acute leukemia: a Children\u2019s Cancer Group Study","volume":"88","author":"Ivy","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib63","first-page":"331","article-title":"Resistance-related proteins in initial and relapsed childhood acute lymphoblastic leukemia","volume":"8","author":"Volm","year":"1996","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib64","first-page":"1083","article-title":"Tumor proliferative compartment, multidrug resistance gene product and apoptosis regulatory p53 and bcl-2 proteins in pediatric acute lymphoblastic leukemia","volume":"4","author":"Srinivas","year":"1997","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejca.2005.09.017_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-911X(199702)28:2<117::AID-MPO5>3.0.CO;2-N","article-title":"Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia","volume":"28","author":"Volm","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib66","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1182\/blood.V91.6.2092.2092_2092_2098","article-title":"Relationship between major vault protein\/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia","volume":"91","author":"den Boer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/08880019809009504","article-title":"Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL","volume":"15","author":"Kanerva","year":"1998","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib68","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002770050388","article-title":"Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India","volume":"76","author":"Gurbuxani","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejca.2005.09.017_bib69","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/sj.leu.2401576","article-title":"Relationship between the intracellular daunorubicin concentration, expression of major vault protein\/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia","volume":"13","author":"den Boer","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib70","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1365-2141.1999.01378.x","article-title":"P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study","volume":"105","author":"Dhooge","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.017_bib71","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1442-200x.1999.01144.x","article-title":"Expression of multidrug resistance-related genes does not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukemia","volume":"41","author":"Kakihara","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ejca.2005.09.017_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00043426-200001000-00009","article-title":"Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia","volume":"22","author":"Ogretmen","year":"2000","journal-title":"J Pediat Hematol Onc"},{"key":"10.1016\/j.ejca.2005.09.017_bib73","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-2141.2000.109004897.x","article-title":"MDR1 mRNA expression in young patients with acute lymphoblastic leukaemia","volume":"109","author":"Gurbuxani","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.017_bib74","first-page":"711","article-title":"Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia","volume":"85","author":"Wuchter","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2005.09.017_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/088800101750059837","article-title":"Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up","volume":"18","author":"Kanerva","year":"2001","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10428190290006080","article-title":"Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: Results of a long-term prospective study","volume":"43","author":"Dhooge","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2005.09.017_bib77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/713842355","article-title":"The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia","volume":"20","author":"De Moerloose","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2005.09.017_bib78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1042819021000040288","article-title":"High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children","volume":"44","author":"Plasschaert","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2005.09.017_bib79","first-page":"1201","article-title":"P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia","volume":"12","author":"Casale","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejca.2005.09.017_bib80","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.leu.2403253","article-title":"In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype","volume":"18","author":"Ramakers-van Woerden","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.leu.2403168","article-title":"Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein","volume":"18","author":"Stam","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib82","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1080\/10428190412331272767","article-title":"Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia","volume":"45","author":"Swerts","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2005.09.017_bib83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/S1516-31802004000400007","article-title":"Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia","volume":"122","author":"Valera","year":"2004","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.ejca.2005.09.017_bib84","first-page":"3010","article-title":"Methods to detect P-glycoprotein-associated multidrug resistance in patients\u2019 tumors: Consensus recommendations","volume":"56","author":"Beck","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib85","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.leu.2400685","article-title":"Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia","volume":"11","author":"Broxterman","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib86","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.leu.2400656","article-title":"Multicentric evaluation of the MDR phenotype in leukemia","volume":"11","author":"Marie","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib87","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.leu.2400691","article-title":"Multidrug resistance in acute leukemia: A comparison of different diagnostic methods","volume":"11","author":"Pall","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib88","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.leu.2401551","article-title":"Testing for tumor drug resistance in the age of molecular medicine. A contribution to the Debate Round-Table on phenotypic and genotypic analysis of multidrug resistance (MDR) in clinical hospital practice","volume":"13","author":"Efferth","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.09.017_bib89","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0006-2952(96)00450-9","article-title":"Multidrug resistance mediated by the multidrug resistance protein (MRP) gene","volume":"52","author":"Lautier","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejca.2005.09.017_bib90","doi-asserted-by":"crossref","first-page":"12322","DOI":"10.1074\/jbc.271.21.12322","article-title":"Membrane topology and glycosylation of the human multidrug resistance-associated protein","volume":"271","author":"Bakos","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.09.017_bib91","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1073\/pnas.93.14.6929","article-title":"ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter","volume":"93","author":"Paul","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib92","first-page":"357","article-title":"Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs","volume":"54","author":"Grant","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib93","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1073\/pnas.91.19.8822","article-title":"The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump","volume":"91","author":"Zaman","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib94","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0026-895X(24)23189-8","article-title":"ATP-dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P","volume":"55","author":"Chen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ejca.2005.09.017_bib95","doi-asserted-by":"crossref","first-page":"27807","DOI":"10.1016\/S0021-9258(18)46856-1","article-title":"The MRP gene encodes an ATP-dependent export pump for leukotriene C4, and structurally related conjugates","volume":"269","author":"Leier","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.09.017_bib96","first-page":"988","article-title":"Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump","volume":"56","author":"Jedlitschky","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BJ20040599","article-title":"The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin","volume":"383","author":"Rigato","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.ejca.2005.09.017_bib98","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.taap.2004.09.008","article-title":"Molecular mechanisms of reduced glutathione transport: role of the MRP\/CFTR\/ABCC and OATP\/SLC21A families of membrane proteins","volume":"204","author":"Ballatori","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ejca.2005.09.017_bib99","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/bjc.1995.144","article-title":"Buthionine Sulfoximine-Mediated Sensitization of Etoposide-Resistant Human Breast-Cancer Mcf7 Cells Overexpressing the Multidrug Resistance-Associated Protein Involves Increased Drug Accumulation","volume":"71","author":"Schneider","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/bjc.1995.281","article-title":"Regulation by glutathione of drug transport in multidrug resistant human lung tumor cell lines overexpressing multidrug resistance-associated protein","volume":"72","author":"Versantvoort","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib101","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1073\/pnas.92.17.7690","article-title":"Role of Glutathione in the Export of Compounds from Cells by the Multidrug-Resistance-Associated Protein","volume":"92","author":"Zaman","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib102","doi-asserted-by":"crossref","first-page":"34166","DOI":"10.1074\/jbc.M004584200","article-title":"Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles","volume":"275","author":"Mao","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.09.017_bib103","first-page":"5238","article-title":"Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione","volume":"57","author":"Lorico","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib104","first-page":"5232","article-title":"Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural produce toxins","volume":"57","author":"Rappa","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/bbrc.1995.1344","article-title":"The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance","volume":"208","author":"Gekeler","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2005.09.017_bib106","first-page":"1961","article-title":"D,L-buthionine- (S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors","volume":"2","author":"Vanhoefer","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(01)00992-X","article-title":"Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells","volume":"421","author":"Salerno","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejca.2005.09.017_bib108","doi-asserted-by":"crossref","first-page":"27846","DOI":"10.1074\/jbc.M102453200","article-title":"Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog","volume":"276","author":"Leslie","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.09.017_bib109","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1074\/jbc.M008251200","article-title":"Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1","volume":"276","author":"Qian","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.09.017_bib110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0022-3565(24)39265-1","article-title":"Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1)","volume":"293","author":"Loe","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejca.2005.09.017_bib111","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1006\/bbrc.2000.3384","article-title":"Structure-activity studies of verapamil analogs that modulate transport of leukotriene C-4 and reduced glutathione by multidrug resistance protein MRP1","volume":"275","author":"Loe","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2005.09.017_bib112","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(01)00681-5","article-title":"Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells","volume":"62","author":"Cullen","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejca.2005.09.017_bib113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1124\/dmd.31.1.11","article-title":"Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1)","volume":"31","author":"Leslie","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ejca.2005.09.017_bib114","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.bcp.2004.08.010","article-title":"Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRP1-mediated efflux of daunorubicin","volume":"68","author":"Salerno","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejca.2005.09.017_bib115","first-page":"1237","article-title":"Tissue distribution of the multidrug resistance protein","volume":"148","author":"Flens","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2005.09.017_bib116","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","article-title":"Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1\u2013ABCC6), in human brain","volume":"129","author":"Nies","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejca.2005.09.017_bib117","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/10428190290017024","article-title":"Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia","volume":"43","author":"Sauerbrey","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2005.09.017_bib118","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1016\/S0021-9258(19)38781-2","article-title":"Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein","volume":"265","author":"Chen","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.09.017_bib119","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.09.017_bib120","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib121","first-page":"5850","article-title":"Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C","volume":"58","author":"Rabindran","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib122","first-page":"145","article-title":"Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR\/BCRP\/ABCP1), in flavopiridol-resistant human breast cancer cells","volume":"7","author":"Robey","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib123","first-page":"5035","article-title":"Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance","volume":"62","author":"Volk","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib124","first-page":"6635","article-title":"Acquired mutations in the MXR\/BCRP\/ABCP gene alter substrate specificity in MXR\/BCRP\/ABCP-overexpressing cells","volume":"61","author":"Honjo","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib125","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2141.2002.03550.x","article-title":"Expression of the BCRP gene (ABCG2\/MXR\/ABCP) in childhood acute lymphoblastic leukaemia","volume":"118","author":"Sauerbrey","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.017_bib127","first-page":"1475","article-title":"Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein mediated multidrug resistance","volume":"53","author":"Scheper","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib128","first-page":"4214","article-title":"The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification","volume":"55","author":"Slovak","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1242\/jcs.106.1.23","article-title":"Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex","volume":"106","author":"Chugani","year":"1993","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ejca.2005.09.017_bib130","first-page":"877","article-title":"Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors","volume":"148","author":"Izquierdo","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2005.09.017_bib131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1168>3.0.CO;2-7","article-title":"Up-regulation of vaults may be necessary but not sufficient for multidrug resistance","volume":"92","author":"Siva","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib132","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1158\/0008-5472.CAN-03-3891","article-title":"Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein\/lung resistance-related protein (vault) expression","volume":"64","author":"van Zon","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib133","first-page":"7298","article-title":"Disruption of the murine major vault protein (MVP\/LRP) gene does not induce hypersensitivity to cytostatics","volume":"62","author":"Mossink","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib134","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/bi047948g","article-title":"Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line","volume":"44","author":"Huffman","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejca.2005.09.017_bib135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1097-0215(20010101)91:1<126::AID-IJC1018>3.0.CO;2-8","article-title":"Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells","volume":"91","author":"Kitazono","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2005.09.017_bib136","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00001813-199708000-00003","article-title":"Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia","volume":"8","author":"Volm","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejca.2005.09.017_bib137","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.8342042","article-title":"Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter","volume":"261","author":"Neefjes","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ejca.2005.09.017_bib138","first-page":"2029","article-title":"Identification of a sister gene to P-glycoprotein","volume":"55","author":"Childs","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib139","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389200043489199","article-title":"The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation","volume":"5","author":"Haimeur","year":"2004","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.ejca.2005.09.017_bib140","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1182\/blood-2002-11-3461","article-title":"The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype","volume":"102","author":"Steinbach","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib141","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2004-08-3303","article-title":"Reproducible measurements of AML blast p-glycoprotein function in 2 center analyses","volume":"105","author":"Pallis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.017_bib142","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/mol.104.005009","article-title":"Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance","volume":"66","author":"Annereau","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ejca.2005.09.017_bib143","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1158\/0008-5472.CAN-04-1978","article-title":"Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes","volume":"64","author":"Gillet","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.09.017_bib144","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905008944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905008944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T03:19:09Z","timestamp":1736133549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804905008944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0959804905008944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2005.09.017","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}